Skip to Content
MarketWatch

Coronavirus tally: Global cases of COVID-19 head toward 160 million and India suffers record one-day death toll

The global tally for the coronavirus-borne illness climbed above 159.7 million on Wednesday, according to data aggregated by Johns Hopkins University (link), while the death toll rose above 3.3 million. The U.S. continues to lead the world in cases and deaths by wide margins, with 32.8 million cases and 582,848 deaths, or about a fifth of the worldwide tallies. India is second to the U.S. by cases at 23.3 million and third by fatalities at 254,197 The World Health Organization said late Tuesday that the double-mutant variant that first emerged there is likely far more transmissible than any other variant but without greater genomic sequencing, it was impossible to be sure, the New York Times reported. (link)Called the B.1.627 variant, it has two spike proteins instead of one. India counted more than 360,000 new cases on Wednesday and 4,200 deaths, the most since the start of the pandemic. Experts say the true numbers are likely far higher, given the stress on India's healthcare system. . Brazil is third with 15.3 million cases and second by fatalities at 425,540. Mexico has the fourth-highest death toll at 219,323 and 2.4 million cases, or 15th highest tally. The U.K. has 4.5 million cases and 127,890 deaths, the fifth-highest in the world and highest in Europe.

-Ciara Linnane; 415-439-6400; AskNewswires@dowjones.com

 

(END) Dow Jones Newswires

05-12-21 0630ET

Copyright (c) 2021 Dow Jones & Company, Inc.

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

We’d like to share more about how we work and what drives our day-to-day business.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

  • Verify your identity, personalize the content you receive, or create and administer your account.
  • Provide specific products and services to you, such as portfolio management or data aggregation.
  • Develop and improve features of our offerings.
  • Gear advertisements and other marketing efforts towards your interests.

To learn more about how we handle and protect your data, visit our privacy center.

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.